ArticleWorld journal of surgical oncology2021

N6-methyladenosine (m6A) RNA methylation regulator SNRPC is a prognostic biomarker and is correlated with immunotherapy in hepatocellular carcinoma.

Jihao Cai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.